A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17921710

Download in:

View as

General Info

PMID
17921710